Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company 13F Holders

BMY Stock Ownership Activity

# of activities:
5
AVG reported price*:
$60.65
Current price*:
+1.24%($61.40)
5 value investing gurus have made changes to the Bristol-Myers Squibb Company (BMY) position according to the gurus' 2026 Q1 SEC quarterly report(s). The number of BMY shares has been increased by 2, decreased by 3 super investor(s).

Which gurus or hedge funds bought BMY in 2026 Q1?

According to the 2026 Q1 SEC filing(s) Bristol-Myers Squibb Company (BMY) has been bought by 2 gurus / funds: Independent Franchise Partners - US Equity Fund (added shares +2.43%) and Tweedy, Browne Co All Funds (US) (added shares +55.31%).
To see more about who is investing in Bristol-Myers Squibb Company (BMY), please go to the BMY ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.